THE LANCET

Commission on Neurorehabilitation

Neurological conditions are highly prevalent affecting at least one in three people in their lifetime. They are the leading cause of disability-adjusted life years (DALYs) and the second leading cause of death globally, with enormous public health impact.

For conditions in which curative interventions are not available or they have only partial effects, multidisciplinary rehabilitative care becomes imperative. This must include interventions to prevent, address and reduce associated limitations, and improve the health-related quality of life and overall well-being of those living with long-term neurological conditions. The overall goal of neurorehabilitation is to improve individual functioning, participation in societal life, and health-related quality of life while maximizing the ability to live a meaningful and productive life. In essence, the purpose of rehabilitation is to add years to life, add life to years, and add meaning to life. 

Therefore, to realize this purpose, this Lancet Commission aims to develop pragmatic solutions to improve neurorehabilitation services across the globe. This Commission seeks to design solutions to overcome barriers in existing services and foster available, accessible, affordable, and effective neurorehabilitation solutions along the continuum of care in diverse settings across the globe. 

Vision

To enhance functioning and improve the participation and quality of life of individuals living with neurological conditions through the development and equitable implementation of pragmatic evidence-based solutions for neurorehabilitation across the globe.

Over-arching goal

To map, harmonize, harness, and leverage global efforts on neurorehabilitation; and translate current evidence to cross-cutting pragmatic solutions for improving functioning, participation, and the quality of life of people with neurological conditions. 

We will also identify evidence gaps and research priorities; and harmonize research activities and implementation strategies based on bio-physical and technological as well as psycho-spiritual and socio-anthropological approaches.

Organisational structure

Prof. Mayowa Ojo Owolabi

Chair

MBBS, MSc, Dr.med., MD, DSc, FMCP, FWACP, FRCP, FAAN, FANA, FAMedS, FAAS, FAS

Director, Center for Genomics and Precision Medicine, 

Consultant Neurologist, Department of Medicine, University College Hospital, Ibadan, Nigeria

& Blossom Center for NeuroRehabilitation, First Center for Neurorehabilitation in East, West and Central Africa, Ibadan, Nigeria

E mail address: mayowaowolabi@yahoo.com

Prof. Thomas Platz

Co -Chair

Medical Director Research

Head Institute for Neurorehabilitation and Evidence-based Practice

BDH-Klinik Greifswald

Head Neurorehabilitation Research Group

Universitätsmedizin Greifswald

E-mail address: t.platz@uni-greifswald.de 

Web site: https://www.medizin.uni-greifswald.de/neurorehabilitation

Ezinne Uvere

Commission administrator

Center for Genomics and Precision Medicine, University College Hospital, Ibadan, Nigeria

E-mail address: ezinneuvere13@gmail.com